Skip to main content

Table 5 Outcomes and cost effectiveness

From: Impact of routine PCV7 (Prevenar) vaccination of infants on the clinical and economic burden of pneumococcal disease in Malaysia

  No
vaccination
PCV7
vaccination
Incremental
Hospitalised cases (n)
Total 83,430 73,845 -9,585
Paediatric 51,933 47,459 -4,474
Adult 31,497 26,386 -5,111
Deaths (n)
Total 1,074 666 -408
Paediatric 639 303 -336
Adult 435 363 -72
Life Years Lost (years)
Total 26,154.00 14,731.60 -11,422.50
Paediatric 19,482.60 9,239.90 -10,242.70
Adult 6,671.40 5,491.60 -1,179.80
Costs (RM million)
Total 255.8 657.9 402
Vaccine 0 439.6 439.6
Hospitalisation episodes 255.8 218.3 -37.5
   Paediatric 137.2 118.9 -18.3
   Adult 118.7 99.4 -19.3
ICER (per life year gained)    RM35,196
(US$10,261)